|
|
|
Search Articles |
|
|
Select Search Criteria |
|
|
Publications: |
|
|
|
Author: |
|
|
| Keywords: |
|
 |
|
|
|
|
|
From: |
mm/dd/yyyy
|
|
|
|
To: |
mm/dd/yyyy
|
 |
|
|
|
Note:
The system displays a max of around 250 records in search result at a time. Please enter a new keyword if the search result does not have the right data. |
|
|
|
|
Circadian Variation in QT Interval Demonstrating Assay Sensitivity in a Phase 1 Clinical Trial
Peter John Bourdillon Drug Information Journal 2010 : 44(01) View Abstract |
|
Reduction of Variability of Response-Adaptive Designs for Continuous Treatment Responses in Phase 3 Clinical Trials Rahul Bhattacharya, Antanu Biswas Drug Information Journal 2010 : 44(01) View Abstract |
|
Rationale for Sponsor-unblinded Phase 1 Trials: Challenging the Doubleblind Paradigm Jitendra Ganju, Clapton Dias Drug Information Journal 2010 : 44(01) View Abstract |
|
Leveraging Technology to Increase Efficiency and Quality for Regulatory SUbmissions Terri M Booth-Genthe, Patricia Sichort Drug Information Journal 2010 : 44(01) View Abstract |
|
Standard Operating Procedures (SOPs): How Companies Can Determine Which Documents THey Must Put in Place Michael R. Hamrell, Janet Gough Drug Information Journal 2010 : 44(01) View Abstract |
|
Biogeneric Regulatory Policies in China and India: A Comparison Study Jeffery W. Guise, Benjamin M. Carson Drug Information Journal 2010 : 44(01) View Abstract |
|
Discussion Based on the Survey Results of Authorities Inquiries During NDA Review in Japan Reiko Numazaki, Yutaka Kawakami, Chikara Kikuchi, Hirofumi Sone, Minako Kasuya, Kazumi Sunamura Drug Information Journal 2010 : 44(01) View Abstract |
|
Mentoring in the Pharmaceutical Industry: Developing an Effective Program for a Field-based Medical Team Barb Schreiner, Jimmy Black Drug Information Journal 2010 : 44(01) View Abstract |
|
|
|
|
|
|
|